Do prescription drug monitoring programs encourage prescription – or illicit – opioid abuse?

References

• St. Louis County Prescription Drug Monitoring Program. PDMP Overview. St. Louis County Web site https://www.stlouisco.com/Health-and-Wellness/PDMP. Accessed March, 1, 2019.
   Google Scholar
• Finklea K, Sacco LN, Bagalman E. Prescription Drug Monitoring Programs. Washington, DC: Congressional Research Service; 2014. CRS Report 7-5700.
   Google Scholar
• Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose. Ann Intern Med. 2010;152(2):85–92.
   PubMed Web of Science ®Google Scholar
• Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007;129(3):355–362.
   PubMed Web of Science ®Google Scholar
• Miller M, Barber CW, Leatherman S, et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. Jama Int Med. 2015;175:608–615.
   PubMed Web of Science ®Google Scholar
• Peirce GL, Smith MJ, Abate MA, Halverson J. Doctor and pharmacy shopping for controlled substances. Medical Care. 2012;50(6):494–500.
   PubMed Web of Science ®Google Scholar
• Dasgupta N, Creppage K, Austin A, Ringwalt C, Sanford C, Proescholdbell SK. Observed transition from opioid analgesic deaths toward heroin. Drug Alcohol Depend. 2014;45:238–241.
   Google Scholar
• Maxwell JC. The pain reliever and heroin epidemic in the United States: shifting winds in the perfect storm. J Addictive Diseases. 2015;34(2–3):127–140.
   PubMed Web of Science ®Google Scholar
• Ali MM, Dowd WN, Classen T, Mutter R, Novak SP. Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: evidence from the National Survey on Drug Use and Health. Addict Behav. 2017;69:65–77.
   PubMed Web of Science ®Google Scholar
• Branham DK. Time-series analysis of the impact of prescription drug monitoring programs on heroin treatment admissions. Subst Use Misuse. 2018;53:694–701.
   PubMed Web of Science ®Google Scholar
• Faryar KA, Freeman CL, Persaud AK, et al. The effects of Kentucky’s comprehensive opioid legislation on patients presenting with prescription opioid or heroin abuse to one urban emergency department. J Emerg Med. 2017;53(6):805–814.
   PubMed Web of Science ®Google Scholar
• Victor GA, Walker R, Cole J, Logan TK. Opioid analgesics and heroin: examining drug misuse trends among a sample of drug treatment clients in Kentucky. Int J Drug Policy. 2017;46:1–6.
   PubMed Web of Science ®Google Scholar
• Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers – United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013;132(1–2):95–100.
   PubMed Web of Science ®Google Scholar
• Lankenau SE, Teti M, Silva K, Bloom JJ, Harocopos A, Treese M. Initiation into prescription opioid misuse among young injection drug users. Int J Drug Policy. 2012;23(1):37–44.
   PubMed Web of Science ®Google Scholar
• Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. Every ‘never’ I ever said came true”: transitions from opioid pills to heroin injecting. Int J Drug Policy. 2014;25(2):257–266.
   PubMed Web of Science ®Google Scholar
• Muhuri PK, Gfroerer JC, Davies MC. Associations of nonmedical pain reliever use and initiation of heroin use in the United States. Center Behav Health Stat Quart. 2013. https://www.samhsa.gov/data/sites/default/files/DR006/DR006/nonmedical-pain-reliever-use-2013.htm
   Google Scholar
• Pollini RA, Banta-Green CJ, Cuevas-Mota J, Metzner M, Teshale E, Garfein RS. Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst Abuse Rehab. 2011;2(1):173–180.
   PubMedGoogle Scholar
• Cicero TJ, Kasper ZA, Ellis MS. Increased use of heroin as an initiating opioid of abuse: further considerations and policy implications. Addict Behav. 2018;87:267–271.
   PubMed Web of Science ®Google Scholar
• Brown R, Riley MR, Ulrich L, et al. Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity. Drug Alcohol Depend. 2017;178:348–354.
   PubMed Web of Science ®Google Scholar
• Meinhofer A. Prescription drug monitoring programs: the role of asymmetric information on drug availability and abuse. Am J Health Econ. 2018;4(4):504–526.
   Web of Science ®Google Scholar
• Paulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death rates from drug overdose. Pain Med. 2011;12(5):747–754.
   PubMed Web of Science ®Google Scholar
• Patrick SW, Fry CE, Jones TF, Buntin MB. Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Affairs. 2016;35(7):1324–1332.
   PubMed Web of Science ®Google Scholar
• Pardo B. Do more robust prescription drug monitoring programs reduce prescription opioid overdose? Addiction 2017;112(10):1773–1783.
   PubMed Web of Science ®Google Scholar
• Horwitz J, Davis CS, McClelland LS, Fordon RS, Meara E. The Problem of Data Quality in Analysis of Opioid Regulation: The Case of Prescription Drug Monitoring Programs. Cambridge, MA: National Bureau of Economic Research; 2018. NBER working paper #24947.
   Google Scholar
• Buchmueller TC, Carey C. The effect of prescription drug monitoring programs on opioid utilization in Medicare. American Economic Journal: Economic Policy. 2018;10(1):77–112.
   Web of Science ®Google Scholar
• Compton WM, Boyle M, Wargo E. Prescription opioid abuse: problems and responses. Prevent Med. 2015;80:5–9.
   PubMed Web of Science ®Google Scholar
• Hewlett L, Wermeling DP. Survey of naloxone legal status in opioid overdose prevention and treatment. J Opioid Manage. 2013;9(5):369–377.
   PubMedGoogle Scholar
• Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010;363(21):1981–1985.
   PubMed Web of Science ®Google Scholar
• Powell D, Pacula RL, Jacobson M. Do medical marijuana laws reduce addictions and deaths related to pain killers? J Health Econ. 2018;58:29–42.
   PubMed Web of Science ®Google Scholar
• Anderson RN, Rosenberg HM. Age standardization of death rates: implementation of the year 2000 standard. Nat Vital Stat Rep. 1988;47:1–20.
   Google Scholar
• Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. J Am Med Assoc. 2011;305(13):1315–1321.
   PubMed Web of Science ®Google Scholar
• Lanier WA, Johnson EM, Rolfs RT, Fiedrichs MD, Grey TC. Risk factors for prescription opioid-related death, Utah, 2008-2009. Pain Med. 2012;13(12):1580–1589.
   PubMed Web of Science ®Google Scholar
• Joynt M, Train MK, Robbins BW, Halterman JS, Caiola E, Fortuna RJ. The impact of neighborhood socioeconomic status and race on the prescribing of opioids in emergency departments throughout the United States. J Gen Intern Med. 2013;28(12):1604–1610.
   PubMed Web of Science ®Google Scholar
• Kohn JL. What is health? A multiple correspondence health index. Eastern Econ J. 2012;38(2):223–250.
   Google Scholar
• Cortinovis I, Vella V, Ndiku J. Construction of a socio-economic index to facilitate analysis of health data in developing countries. Social Sci Med. 2012;36(8):1087–1097.
   Google Scholar
• Ezzrari A, Verme P. A Multiple Correspondence Analysis Approach to the Measurement of Multidimensional Poverty in Morocco, 2001-2007. Washington, DC: World Bank; 2012. World Bank Policy Research Working Paper #6087.
   Google Scholar
• Abdi H, Valentin D. Multiple correspondence analysis. In: Salkind N, ed. Encyclopedia of Measurement and Statistics. Thousand Oaks, CA: SAGE Publications Inc.; 2006:1–13
   Google Scholar
• Hill MO, Smith A. Principal component analysis of taxonomic data with multi-state discrete characters. Taxon 1976;25(2–3):249–255.
   Web of Science ®Google Scholar
• Kolenikov S, Angeles G. Socioeconomic status measurement with discrete proxy variables is principal component analysis a reliable answer? Rev Income Wealth. 2009;55(1):128–165.
   Web of Science ®Google Scholar
• Sourial N, Wolfson C, Zhu B, et al. Correspondence analysis is a useful tool to uncover the relationships among categorical variables. J Clin Epidemiol. 2010;63(6):638–646.
   PubMed Web of Science ®Google Scholar
• Seplaki CL, Agree EM, Weiss CO, Szanton SL, Bandeen-Roche K, Fried LP. Assistive devices in context: cross-sectional association between challenges in the home environment and use of assistive devices for mobility. The Gerontol. 2014;54(4):651–660.
   Google Scholar
• Dowell D, Zhang K, Noonan RK, Hockenberry JM. Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates. Health Affairs. 2016;35(10):1876–1883.
   PubMed Web of Science ®Google Scholar
• Grecu AM, Dave DM, Saffer H. Mandatory access prescription drug monitoring programs and prescription drug abuse. J Pol Anal Manage. 2019;38(1):181–209.
   PubMed Web of Science ®Google Scholar
• Rasubala L, Pernapati L, Valasquez X, Burk J, Ren YF. Impact of a mandatory prescription drug monitoring program on prescription of opioid analgesics by dentists. PLoS One. 2015;10:110.
   Web of Science ®Google Scholar
• Winstanley EL, Zhang Y, Mashni R, et al. Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing. Drug Alcohol Depend. 2018;188:169–174.
   PubMed Web of Science ®Google Scholar
• Lin DH, Lucas E, Murimi IB, et al. Physician attitudes and experiences with Maryland’s prescription drug monitoring program. Addiction 2017;112(2):311–319.
   PubMed Web of Science ®Google Scholar
• Rutkow L, Turner L, Lucas E, Hwang C, Alexander GC. Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access. Health Affairs. 2015;34(3):484–492.
   PubMed Web of Science ®Google Scholar
• Inciardi JA, Surratt HL, Cicero TJ, Beard RA. Prescription opioid abuse and diversion in an urban community. Pain Med. 2009;10(3):537–548.
   PubMed Web of Science ®Google Scholar
• Davis WR, Johnson BD. Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend. 2008;92(1–3):267–276.
   PubMed Web of Science ®Google Scholar
• Ciccarone D. Editorial for “U.S. heroin in transition: supply changes, fentanyl adulteration and consequences” IJDP special section. Int J Drug Policy. 2017;46:107–111.
   PubMed Web of Science ®Google Scholar
• Frank RG, Pollack HA. Addressing the fentanyl threat to public health. N Engl J Med. 2017;376(7):605–607.
   PubMed Web of Science ®Google Scholar